587 related articles for article (PubMed ID: 27520374)
1. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
2. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
3. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Hernandez P; Lee G; Sjoberg M; Maccioni RB
J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
5. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
6. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.
Li C; Götz J
EMBO J; 2017 Nov; 36(21):3120-3138. PubMed ID: 28864542
[TBL] [Abstract][Full Text] [Related]
7. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA SOX21-AS1 attenuates amyloid-β-induced neuronal damage by sponging miR-107.
Xu W; Li K; Fan Q; Zong B; Han L
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32124921
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of tau by fyn: implications for Alzheimer's disease.
Lee G; Thangavel R; Sharma VM; Litersky JM; Bhaskar K; Fang SM; Do LH; Andreadis A; Van Hoesen G; Ksiezak-Reding H
J Neurosci; 2004 Mar; 24(9):2304-12. PubMed ID: 14999081
[TBL] [Abstract][Full Text] [Related]
10. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
[TBL] [Abstract][Full Text] [Related]
12. The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease.
Larson M; Sherman MA; Amar F; Nuvolone M; Schneider JA; Bennett DA; Aguzzi A; Lesné SE
J Neurosci; 2012 Nov; 32(47):16857-71a. PubMed ID: 23175838
[TBL] [Abstract][Full Text] [Related]
13. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.
Li J; Chen W; Yi Y; Tong Q
J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
15. Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.
Zahratka JA; Shao Y; Shaw M; Todd K; Formica SV; Khrestian M; Montine T; Leverenz JB; Bekris LM
Neurobiol Aging; 2017 Mar; 51():43-53. PubMed ID: 28033507
[TBL] [Abstract][Full Text] [Related]
16. Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.
Iannuzzi F; Sirabella R; Canu N; Maier TJ; Annunziato L; Matrone C
Cells; 2020 Jul; 9(8):. PubMed ID: 32751526
[TBL] [Abstract][Full Text] [Related]
17. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
Liu Y; Wang L; Xie F; Wang X; Hou Y; Wang X; Liu J
Curr Neurovasc Res; 2020; 17(3):241-248. PubMed ID: 32286945
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
Huang W; Li Z; Zhao L; Zhao W
Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
Pan K; Chen S; Wang Y; Yao W; Gao X
Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]